These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 32582959

  • 1. MicroRNA‑103 modulates tumor progression by targeting KLF7 in non‑small cell lung cancer.
    Li K, Yuan C.
    Int J Mol Med; 2020 Sep; 46(3):1013-1028. PubMed ID: 32582959
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. miR-185 Inhibits the Proliferation and Invasion of Non-Small Cell Lung Cancer by Targeting KLF7.
    Zhao L, Zhang Y, Liu J, Yin W, Jin D, Wang D, Zhang W.
    Oncol Res; 2019 Sep 23; 27(9):1015-1023. PubMed ID: 29716672
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. miR-200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non-small cell lung cancer cells.
    Tang Q, Li M, Chen L, Bi F, Xia H.
    Int J Oncol; 2018 Oct 23; 53(4):1732-1742. PubMed ID: 30066855
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Silencing of ISLR inhibits tumour progression and glycolysis by inactivating the IL‑6/JAK/STAT3 pathway in non‑small cell lung cancer.
    Zhang P, Li Z, Yang G.
    Int J Mol Med; 2021 Dec 23; 48(6):. PubMed ID: 34713300
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. ΜicroRNA‑421 promotes the progression of non‑small cell lung cancer by targeting HOPX and regulating the Wnt/β‑catenin signaling pathway.
    Liang H, Wang C, Gao K, Li J, Jia R.
    Mol Med Rep; 2019 Jul 23; 20(1):151-161. PubMed ID: 31115507
    [Abstract] [Full Text] [Related]

  • 11. IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression.
    Xue D, Yang P, Wei Q, Li X, Lin L, Lin T.
    Int J Mol Med; 2019 Nov 23; 44(5):1697-1706. PubMed ID: 31573051
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Propofol suppresses the progression of non‑small cell lung cancer via downregulation of the miR‑21‑5p/MAPK10 axis.
    Wu X, Li X, Xu G.
    Oncol Rep; 2020 Aug 23; 44(2):487-498. PubMed ID: 32468043
    [Abstract] [Full Text] [Related]

  • 14. NORAD regulates epithelial‑mesenchymal transition of non‑small cell lung cancer cells via miR‑422a.
    Chen Z, Che Q, Xie C.
    Mol Med Rep; 2021 Feb 23; 23(2):. PubMed ID: 33300080
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells.
    Tang H, Lv W, Sun W, Bi Q, Hao Y.
    Int J Mol Med; 2019 Mar 23; 43(3):1203-1216. PubMed ID: 30628663
    [Abstract] [Full Text] [Related]

  • 18. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM, Zheng Y, Wang P, Zheng L, Zhang WL, Di Y, Chen LL, Yin XB, Tian Q, Shi SS, Xu SF.
    Am J Physiol Lung Cell Mol Physiol; 2019 May 01; 316(5):L918-L933. PubMed ID: 30628487
    [Abstract] [Full Text] [Related]

  • 19. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
    Li Y, Zhang H, Li Y, Zhao C, Fan Y, Liu J, Li X, Liu H, Chen J.
    Mol Carcinog; 2018 Jan 01; 57(1):125-136. PubMed ID: 28940757
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.